2.0
Apr 10, 2026
Current employee, more than 3 years
Foster City, CA
Recommend
CEO approval
Business Outlook
Pros
Higher pay than avg. Surrounded by good researchers. Strong virology.
Cons
Promotion cycle stalled. Good people are leaving. New hires are based on if they are from amgen, than anything else. Onc and inflam haven't shown much promising outcome since the new EVP joined. A lot of resources and effort lead to nothing due to poor leadership decisions.